表纸
市场调查报告书

质子治疗的美国市场:患者数,偿付政策,在质子治疗中心治疗中的患者数

United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers

出版商 Renub Research 商品编码 484586
出版日期 内容资讯 英文 147 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
质子治疗的美国市场:患者数,偿付政策,在质子治疗中心治疗中的患者数 United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers
出版日期: 2019年08月01日内容资讯: 英文 147 Pages
简介

本报告提供美国的质子治疗市场相关调查分析,显在市场与潜在市场为对象,患者数,癌症的种类,治疗中心的清单,经济性,企业分析等相关的系统性资讯。

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 市场 (显然存在、潜在) - 美国的质子治疗市场

  • 质子治疗:显然存在市场
  • 质子治疗:潜在市场

第5章 患者数 - 美国的质子治疗

  • 实数
  • 潜在数

第6章 癌症的种类 - 美国的质子治疗的患者数

  • 中枢神经系统 (CNS) 肿瘤
  • 眼球内黑色素瘤
  • 下垂体肿瘤
  • 顱底/主轴骨骼肿瘤
  • 头颈椎癌症
  • 肺癌症
  • 后腹膜肉瘤
  • 儿童癌症 (18岁以下)
  • 消化管癌症
  • 尿路癌症
  • 女性、骨盆内脏器癌症
  • 前列腺癌症
  • 乳癌
  • 其他

第7章 癌症的种类 - 美国的质子治疗市场

  • 中枢神经系统 (CNS) 肿瘤
  • 眼球内黑色素瘤
  • 下垂体肿瘤
  • 顱底/主轴骨骼肿瘤
  • 头颈椎癌症
  • 肺癌症
  • 后腹膜肉瘤
  • 儿童癌症 (18岁以下)
  • 消化管癌症
  • 尿路癌症
  • 女性、骨盆内脏器癌症
  • 前列腺癌症
  • 乳癌
  • 其他

第8章 美国 - 质子治疗中心的清单

  • 运作中
  • 建设中
  • 计划中

第9章 各中心 - 治疗中的患者数

  • Loma Linda (LLUMC) Proton Therapy Center
  • UCSF - CNL Proton Therapy Center
  • Boston (NPTC) Proton Therapy Center
  • Bloomington (MPRI, 2) Proton Therapy Center
  • Houston (MD Anderson) Proton Therapy Center
  • UFPTI Jacksonville Proton Therapy Center
  • Oklahoma City (ProCure PTC) Proton Therapy Center
  • CDH Warrenville Proton Therapy Center
  • Philadelphia (Upenn) Proton Therapy Center
  • Hampton (HUPTI) Proton Therapy Center
  • New Jersey (ProCure PTC) Proton Therapy Center
  • Seattle (SCCA ProCure PTC) Proton Therapy Center
  • St. Louis (S. Lee King PTC) Proton Therapy Center
  • Provision Center for Proton Therapy, Knoxville, TN
  • San Diego (Scripps PTC) (2014 - 2017)
  • Shreveport (Willis Knighton) Proton Therapy Center
  • Jacksonville (Ackerman CC) Proton Therapy Center
  • Rochester (Mayo PBTC) Proton Therapy Center
  • Brunswick (Laurie PC) Proton Therapy Center
  • Irving (Texas Center for PT) Proton Therapy Center
  • Memphis (St. Jude PTC) Proton Therapy Center
  • Phoenix (Mayo PBTC) Proton Therapy Center
  • Baltimore (Maryland PTC) Proton Therapy Center
  • Cincinnati (Children's PTC) Proton Therapy Center
  • Orlando (Orlando Health PTC) Proton Therapy Center
  • Cleveland (UH Sideman PTC) Proton Therapy Center

第10章 质子治疗 - 偿付政策

  • 患者
  • 医疗机关、相关利益者、厂商

第11章 标准的质子治疗中心的结构要素

  • 质子加速器
  • 射束传输系统
  • 电子束提供系统
  • 管嘴
  • 治疗计划系统
  • 影像查看器
  • 患者定位系统 (PPS)
  • 人力资源

第12章 企业分析

  • IBA Proton Therapy
  • Varian Medical Systems
  • Elekta

第13章 促进因素

第14章 课题

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

United States is the hub of proton therapy industry where various advanced and children specialist centers and preferential facilities are available for the child. In United States, currently 31 proton therapy centers are operational, and many centers are in the constructional phase and planning phase. Proton therapy centers are growing at a rapid pace in United States as its cancer incidences are raising and there are more patients eligible for treatment than actually resources available for them. Proton therapy is one of the advanced techniques of radiotherapy which produces optimal amount of radiation or pinpoint radiation to kill tumor and mitigate radiation exposure to healthy tissues or cells. The potential of United States Proton Therapy Market is expected to be more than USD 16 Billion by the end of year 2025. But the actual market is merely 10% of the potential market due to demand-supply mismatch.

Proton therapy is a non-invasive procedure that is used for the treatment of multiple cancers like CNS Cancer, Head & Neck Cancer, Prostate Cancer, Breast Cancer and Lung Cancer etc. People across the world are looking for the non-invasive procedure because of its effectiveness and painless outcome. The clinical benefit of using proton therapy is its minimal side effects because proton therapy affects less radiation to healthy tissues or cells.

Besides, proton therapy can be an effective treatment for recurrent tumors. Proton therapy is one of the effective treatments for pediatric patients rather than conventional radiotherapy and surgery that include various risks and complications. Additionally, children body is prone to the re-occurrence of cancer and proton therapy plays an essential role by preventing from re-occurrence. The survival rate of proton therapy is nearly 90 percent which is far better than the traditional technique to treat cancer.

"United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" is a report published by Renub Research. In this report, we have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about the list of all operational and Proton Therapy centers going to open in future; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

  • 1. Actual Market is the current market which is already present
  • 2. Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year

Patient Numbers for the Treatment of Proton Therapy in United States

In this report, we have portrayed proton therapy patients into two parts; potential patients and actual one. We have also categorized the proton therapy patient numbers on the basis of cancer type into 14 sections; Central Nervous System Tumors, Intraocular Melanomas, Pituitary Neoplasms, Base of Skull / Axial Skeleton, Head and Neck, Lung Cancers, Retroperitoneal Sarcoma, Pediatric (Up to Age 18), Gastrointestinal Tract, Urinary Tract, Female Pelvic Organs, Prostate Cancer, Breast Cancer and Other.

Proton Therapy Market for 14 Types of Cancer in United States

The proton therapy market is divided into two parts; potential proton therapy market and actual proton therapy market. This report studies the 14 cancer types proton therapy market Retroperitoneal Sarcoma, Central Nervous System Tumors, Pituitary Neoplasms, Intraocular Melanomas, Lung Cancers, Base of Skull / Axial Skeleton, Gastrointestinal Tract, Pediatric (Up to Age 18), Urinary Tract, Head and Neck, Breast Cancer, Female Pelvic Organs, Prostate Cancer, and Other.

According to Renub Research Analysis, the more patients of cancer would get proton therapy treatment in United States due to rising prevalence of cancer and an increasing number of the advanced proton therapy center. Additionally, increasing technological development in Proton therapy and increasing efficiencies will further boost the market of proton therapy in United States.

Number of Patients Treated in each Proton Therapy Center of United States

In this report, we have done a full assessment of proton therapy center of United States with their treatment capabilities and technology used. Currently, there are 31 operational centers for proton therapy in United States, and XX centers are in construction phase and XX are in planning phase. In this report we have provided complete patients number treated with proton therapy by each proton therapy center of United States.

Reimbursement Policy Insights

Here, we have done an in-depth analysis of reimbursement policies in United States. Here, we have fragmented the reimbursement policy into two parts; the first one is by patient's perspective, and the second one is by manufacturer, stakeholder and institutional perspective.

Key Companies Covered

  • 1. IBA (Overview, Sales Analysis)
  • 2. Varian Medical Systems (Overview, Sales Analysis)
  • 3. Elekta (Overview, Sales Analysis)

United States Proton Therapy Market & Patient Numbers has been analyzed from two viewpoints

  • Actual & Potential Market
  • Actual & Potential Number of Patients Treated

14 Types of Cancer - Patient Numbers & Market

  • 1. Central Nervous System Tumors Cancer
  • 2. Pituitary Neoplasms Cancer
  • 3. Intraocular Melanomas Cancer
  • 4. Lung Cancers
  • 5. Base of Skull / Axial Skeleton Cancer
  • 6. Gastrointestinal Tract Cancer
  • 7. Pediatric (Up to Age 18) Cancer
  • 8. Urinary Tract Cancer
  • 9. Head and Neck Cancer
  • 10. Breast Cancer
  • 11. Female Pelvic Organs Cancer
  • 12. Prostate Cancer
  • 13. Retroperitoneal Sarcoma Cancer
  • 14. Other Cancer

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market (Actual & Potential) - United States Proton Therapy Market (2009 - 2025)

  • 4.1. Actual Proton Therapy Market
  • 4.2. Potential Proton Therapy Market

5. Number of Patients - United States Proton Therapy (2009 - 2025)

  • 5.1. Actual Numbers
  • 5.2. Potential Numbers

6. Cancer Types - Patients Number in United States Proton Therapy (2009 - 2025)

  • 6.1. Central Nervous System Tumors
  • 6.2. Intraocular Melanomas Cancer
  • 6.3. Pituitary Neoplasms Cancer
  • 6.4. Base of Skull / Axial Skeleton Cancer
  • 6.5. Head and Neck Cancer
  • 6.6. Lung Cancer
  • 6.7. Retroperitoneal Sarcoma Cancer
  • 6.8. Pediatric Cancer Cases (Up to Age 18)
  • 6.9. Gastrointestinal Tract Cancer
  • 6.10. Urinary Tract Cancer
  • 6.11. By Female Pelvic Organs Cancer
  • 6.12. Prostate Cancer
  • 6.13. Breast Cancer
  • 6.14. Other Cancer

7. Cancer Types - United States Proton Therapy Market (2009 - 2025)

  • 7.1. Central Nervous System Tumors
  • 7.2. Intraocular Melanomas Cancer
  • 7.3. Pituitary Neoplasms Cancer
  • 7.4. Base of Skull / Axial Skeleton Cancer
  • 7.5. Head and Neck Cancer
  • 7.6. Lung Cancer
  • 7.7. Retroperitoneal Sarcoma Cancer
  • 7.8. Pediatric Cancer (Up to Age 18)
  • 7.9. Gastrointestinal Tract Cancer
  • 7.10. Urinary Tract Cancer
  • 7.11. Female Pelvic Organs Cancer
  • 7.12. Prostate Cancer
  • 7.13. Breast Cancer
  • 7.14. Other Cancer

8. United States - List of Proton Therapy Centers

  • 8.1. Operating Proton Therapy Centers
  • 8.2. Under-Construction Therapy Centers
  • 8.3. Planning Proton Therapy Centers

9. By Centers - Number of Proton Therapy Patients Treated

  • 9.1. Loma Linda (LLUMC) Proton Therapy Center (2008 - 2016)
  • 9.2. UCSF - CNL Proton Therapy Center (2008 - 2015)
  • 9.3. Boston (NPTC) Proton Therapy Center (2008 - 2016)
  • 9.4. Bloomington (MPRI, 2) Proton Therapy Center (2008 - 2014)
  • 9.5. Houston (MD Anderson) Proton Therapy Center (2008 - 2016)
  • 9.6. UFPTI Jacksonville Proton Therapy Center (2008 - 2016)
  • 9.7. Oklahoma City (ProCure PTC) Proton Therapy Center (2009 - 2017)
  • 9.8. CDH Warrenville Proton Therapy Center (2010 - 2016)
  • 9.9. Philadelphia (Upenn) Proton Therapy Center (2011 - 2016)
  • 9.10. Hampton (HUPTI) Proton Therapy Center (2012 - 2016)
  • 9.11. New Jersey (ProCure PTC) Proton Therapy Center (2012 - 2016)
  • 9.12. Seattle (SCCA ProCure PTC) Proton Therapy Center (2013 - 2016)
  • 9.13. St. Louis (S. Lee King PTC) Proton Therapy Center (2013 - 2016)
  • 9.14. Provision Center for Proton Therapy, Knoxville, TN (2014 - 2016)
  • 9.15. San Diego (Scripps PTC) (2014 - 2017)
  • 9.16. Shreveport (Willis Knighton) Proton Therapy Center (2014 - 2017)
  • 9.17. Jacksonville (Ackerman CC) Proton Therapy Center (2015 - 2016)
  • 9.18. Rochester (Mayo PBTC) Proton Therapy Center (2015 - 2016)
  • 9.19. Brunswick (Laurie PC) Proton Therapy Center (2015)
  • 9.20. Irving (Texas Center for PT) Proton Therapy Center (2015 - 2017)
  • 9.21. Memphis (St. Jude PTC) Proton Therapy Center (2015 - 2017)
  • 9.22. Phoenix (Mayo PBTC) Proton Therapy Center (2016)
  • 9.23. Baltimore (Maryland PTC) Proton Therapy Center (2016)
  • 9.24. Cincinnati (Children's PTC) Proton Therapy Center (2016)
  • 9.25. Orlando (Orlando Health PTC) Proton Therapy Center (2016)
  • 9.26. Cleveland (UH Sideman PTC) Proton Therapy Center (2016)

10. Proton Therapy - Reimbursement Policies

  • 10.1. Proton Therapy Reimbursement Policies for Patients
  • 10.2. Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

11. Components of a Standard Proton Therapy Center

  • 11.1. Proton Accelerator
    • 11.1.1. Synchrotrons (example: LLUMC at Loma Linda)
    • 11.1.2. Cyclotrons (example: MGH Boston)
    • 11.1.3. Synchrocyclotrons (examples: Orsay, Uppsala)
    • 11.1.4. Linacs (Rome)
    • 11.1.5. H-minus Synchrotrons
    • 11.1.6. Separated Sector Cyclotrons
    • 11.1.7. Super-conducting Cyclotrons
    • 11.1.8. Fast Cycling Synchrotron
  • 11.2. Beam Transport System
  • 11.3. Beam Delivery System
    • 11.3.1. The Passive Scattering Technique
    • 11.3.2. Beam Scanning
  • 11.4. Nozzle
    • 11.4.1. Single Scattering
    • 11.4.2. Double Scattering
    • 11.4.3. Uniform Scanning Nozzle
    • 11.4.4. Pencil Scanning Nozzle
  • 11.5. Treatment Planning System
  • 11.6. Image Viewers
  • 11.7. Patient Positioning System (PPS)
  • 11.8. Human Resource

12. Company Analysis (2014 - 2025)

  • 12.1. IBA Proton Therapy
    • 12.1.1. Sales Analysis
  • 12.2. Varian Medical Systems
    • 10.2.2. Sales Analysis
  • 12.3. Elekta
    • 12.3.1. Sales Analysis

13. Driving Factors

  • 13.1. Technology Advancement
    • 13.1.1. Next-Generation Proton Technique
  • 13.2. Growing Incidence of Cancer Patients in United States

14. Challenges

  • 14.1. Requires Huge Investment
  • 14.2. Operations Challenges

List of Figures:

  • Figure 2-1: United States - Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-2: United States - Forecast for Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 2-3: United States - Potential Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-4: United States - Forecast for Potential Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 3-1: United States - Patient Treated with Proton Therapy (Number), 2009 - 2018
  • Figure 3-2: United States - Forecast for Patient Treated with Proton Therapy (Number), 2019 - 2025
  • Figure 3-3: United States - Potential Candidate for Proton Therapy (Number), 2009 - 2018
  • Figure 3-4: United States - Forecast for Potential Candidate for Proton Therapy (Number), 2019 - 2025
  • Figure 4-1: United States - Proton Therapy Patient by Central Nervous System Tumors (Number), 2009 - 2018
  • Figure 4-2: United States - Forecast for Proton Therapy Patient by Central Nervous System Tumors (Number), 2019 - 2025
  • Figure 4-3: United States - Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2009 - 2018
  • Figure 4-4: United States - Forecast for Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2019 - 2025
  • Figure 4-5: United States - Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2009 - 2018
  • Figure 4-6: United States - Forecast for Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2019 - 2025
  • Figure 4-7: United States - Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2009 - 2018
  • Figure 4-8: United States - Forecast for Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2019 - 2025
  • Figure 4-9: United States - Proton Therapy Patient by Head and Neck Cancer (Number), 2009 - 2018
  • Figure 4-10: United States - Forecast for Proton Therapy Patient by Head and Neck Cancer (Number), 2019 - 2025
  • Figure 4-11: United States - Proton Therapy Patient by Lung Cancer (Number), 2009 - 2018
  • Figure 4-12: United States - Forecast for Proton Therapy Patient by Lung Cancer (Number), 2019 - 2025
  • Figure 4-13: United States - Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2009 - 2018
  • Figure 4-14: United States - Forecast for Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2019 - 2025
  • Figure 4-15: United States - Proton Therapy Patient by Pediatric Cancer (Number), 2009 - 2018
  • Figure 4-16: United States - Forecast for Proton Therapy Patient by Pediatric Cancer (Number), 2019 - 2025
  • Figure 4-17: United States - Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2009 - 2018
  • Figure 4-18: United States - Forecast for Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2019 - 2025
  • Figure 4-19: United States - Proton Therapy Patient by Urinary Tract Cancer (Number), 2009 - 2018
  • Figure 4-20: United States - Forecast for Proton Therapy Patient by Urinary Tract Cancer (Number), 2019 - 2025
  • Figure 4-21: United States - Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2009 - 2018
  • Figure 4-22: United States - Forecast for Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2019 - 2025
  • Figure 4-23: United States - Proton Therapy Patient by Prostate Cancer (Number), 2009 - 2018
  • Figure 4-24: United States - Forecast for Proton Therapy Patient by Prostate Cancer (Number), 2019 - 2025
  • Figure 4-25: United States - Proton Therapy Patient by Breast Cancer (Number), 2009 - 2017
  • Figure 4-26: United States - Forecast for Proton Therapy Patient by Breast Cancer (Number), 2019 - 2025
  • Figure 4-27: United States - Proton Therapy Patient by Other Cancer (Number), 2009 - 2018
  • Figure 4-28: United States - Forecast for Proton Therapy Patient by Other Cancer (Number), 2019 - 2025
  • Figure 5-1: United States - Proton Therapy Market by Central Nervous System Tumors (Million US$), 2009 - 2018
  • Figure 5-2: United States - Forecast for Proton Therapy Market by Central Nervous System Tumors (Million US$), 2019 - 2025
  • Figure 5-3: United States - Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2009 - 2018
  • Figure 5-4: United States - Forecast for Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2019 - 2025
  • Figure 5-5: United States - Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2009 - 2018
  • Figure 5-6: United States - Forecast for Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2019 - 2025
  • Figure 5-7: United States - Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2009 - 2018
  • Figure 5-8: United States - Forecast for Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2019 - 2025
  • Figure 5-9: United States - Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 - 2018
  • Figure 5-10: United States - Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2019 - 2025
  • Figure 5-11: United States - Proton Therapy Market by Lung Cancer (Million US$), 2009 - 2018
  • Figure 5-12: United States - Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2019 - 2025
  • Figure 5-13: United States - Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2009 - 2018
  • Figure 5-14: United States - Forecast for Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2019 - 2025
  • Figure 5-15: United States - Proton Therapy Market by Pediatric Cancer (Million US$), 2009 - 2018
  • Figure 5-16: United States - Forecast for Proton Therapy Market by Pediatric Cancer (Million US$), 2019 - 2025
  • Figure 5-17: United States - Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2009 - 2018
  • Figure 5-18: United States - Forecast for Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2019 - 2025
  • Figure 5-19: United States - Proton Therapy Market by Urinary Tract Cancer (Million US$), 2009 - 2018
  • Figure 5-20: United States - Forecast for Proton Therapy Market by Urinary Tract Cancer (Million US$), 2019 - 2025
  • Figure 5-21: United States - Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2009 - 2018
  • Figure 5-22: United States - Forecast for Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2019 - 2025
  • Figure 5-23: United States - Proton Therapy Market by Prostate Cancer (Million US$), 2009 - 2018
  • Figure 5-24: United States - Forecast for Proton Therapy Market by Prostate Cancer (Million US$), 2019 - 2025
  • Figure 5-25: United States - Proton Therapy Market by Breast Cancer (Million US$), 2009 - 2018
  • Figure 5-26: United States - Forecast for Proton Therapy Market by Breast Cancer (Million US$), 2019 - 2025
  • Figure 5-27: United States - Proton Therapy Market by Other Cancer (Million US$), 2009 - 2018
  • Figure 5-28: United States - Forecast for Proton Therapy Market by Other Cancer (Million US$), 2019 - 2025
  • Figure 10-1: Global - IBA Proton Therapy Sales (Million US$), 2014 - 2018
  • Figure 10-2: Global - Forecast for IBA Proton Therapy Sales (Million US$), 2019 - 2025
  • Figure 10-3: Global - Varian Medical Systems Oncology Systems Sales (Million US$), 2014 - 2018
  • Figure 10-4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2019 - 2025
  • Figure 10-5: Global - Elekta Revenue, (Million USD), 2014 - 2018
  • Figure 10-6: Global - Forecast for Elekta Revenue, (Million US$), 2019 - 2025
  • Figure 11-1: United States - Numbers of Patient Diagnosed With cancer (In Number), 2014 - 2018
  • Figure 11-2: United States - Forecast for Numbers of Patient Diagnosed With cancer (In Number), 2019 - 2025
Back to Top